Trial Profile
A randomized controlled study of postoperative adjuvant chemotherapy of UFT compared with surgery alone for serosa-negative advanced gastric cancer (NSAS-GC)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 May 2016
Price :
$35
*
At a glance
- Drugs Tegafur/uracil (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 07 Jul 2008 Actual completion date Aug 2007 added as reported by ClinicalTrials.gov.
- 07 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 20 Oct 2005 New trial record.